{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:06:37Z","timestamp":1792785997618,"version":"4.5.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA213140"],"award-info":[{"award-number":["U01CA213140"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA078938"],"award-info":[{"award-number":["R01CA078938"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Leukemia Lymphoma Society"},{"name":"Swedish Childhood Cancer Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Human papillomavirus (HPV) is associated with an increased risk for a variety of squamous cell carcinomas in the general population. The risk for subsequent squamous cell carcinomas in blood or marrow transplantation survivors that are potentially related to HPV (cervical, oropharyngeal, vulvar, vaginal, anal, and penile cancer; HPV-related squamous cell carcinomas) remains unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We determined the risk of HPV-related squamous cell carcinomas in 7936 2-year survivors of autologous or allogeneic blood or marrow transplantation performed between 1974 and 2014 and identified the role of demographic and clinical factors associated with HPV-related squamous cell carcinomas using proportional subdistribution hazards model for competing risks. Standardized incidence ratio was used to compare the risk of HPV-related squamous cell carcinoma with age-, sex-, and calendar-specific incidence in the general population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median age at transplantation was 46\u2009years (range = 0-78\u2009years); 58.5% (n\u2009=\u20094642) were male, and 72.2% (n\u2009=\u20095727) were non-Hispanic White. Half (50.3%, n\u2009=\u20093991) of the patients had received an allogeneic blood or marrow transplantation. The standardized incidence ratio for oropharyngeal squamous cell carcinomas (n\u2009=\u200953) was 1.8 (95% confidence interval [CI]\u2009=\u20091.3 to 2.3) and for cervical squamous cell carcinoma among female blood or marrow transplantation recipients (n\u2009=\u200926) was 9.4 (95% CI\u2009=\u20096.3 to 13.6) compared with the general US population. The hazard of an HPV-related squamous cell carcinoma was higher among allogeneic blood or marrow transplantation recipients with chronic graft vs host disease (any HPV-related squamous cell carcinoma: HR\u2009=\u20096.24, 95% CI\u2009=\u20093.11 to 12.50; oropharyngeal: HR\u2009=\u20094.85, 95% CI\u2009=\u20092.11 to 11.15; cervical: HR\u2009=\u20094.98, 95% CI\u2009=\u20091.65 to 15.00; reference: autologous blood or marrow transplantation). Pre-blood or marrow transplantation radiation increased the risk of oropharyngeal squamous cell carcinoma (HR\u2009=\u20092.98, 95% CI\u2009=\u20091.57 to 5.65).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings underscore the importance of risk-based HPV vaccination and surveillance after blood or marrow transplantation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jnci\/djaf021","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T07:14:52Z","timestamp":1737962092000},"page":"1166-1174","source":"Crossref","is-referenced-by-count":4,"title":["Human papillomavirus\u2013related squamous cell carcinomas after blood or marrow transplantation\u2014a Blood or Marrow Transplant Survivor Study report"],"prefix":"10.1093","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3756-8148","authenticated-orcid":false,"given":"Anna S\u00e4llfors","family":"Holmqvist","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences, Lund University, Childhood Cancer Center, Sk\u00e5ne University Hospital , Lund,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingrui","family":"Meng","sequence":"additional","affiliation":[{"name":"Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham School of Medicine , Birmingham, AL 35233,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3319-5652","authenticated-orcid":false,"given":"Wendy","family":"Landier","sequence":"additional","affiliation":[{"name":"Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham School of Medicine , Birmingham, AL 35233,","place":["United States"]},{"name":"Division of Pediatric Hematology, Oncology and Bone Marrow Transplantation, University of Alabama at Birmingham , Birmingham, AL 35233,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Hageman","sequence":"additional","affiliation":[{"name":"Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham School of Medicine , Birmingham, AL 35233,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8138-9932","authenticated-orcid":false,"given":"Liton F","family":"Francisco","sequence":"additional","affiliation":[{"name":"Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham School of Medicine , Birmingham, AL 35233,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Schlichting","family":"Ross","sequence":"additional","affiliation":[{"name":"Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham School of Medicine , Birmingham, AL 35233,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8371-8821","authenticated-orcid":false,"given":"Nora","family":"Balas","sequence":"additional","affiliation":[{"name":"Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham School of Medicine , Birmingham, AL 35233,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0662-5699","authenticated-orcid":false,"given":"Alysia","family":"Bosworth","sequence":"additional","affiliation":[{"name":"Population Sciences, City of Hope , Duarte, CA 91919,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hok Sreng","family":"Te","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology and Transplantation, University of Minnesota , Minneapolis, MN 55455,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Bhatia","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology and Bone Marrow Transplantation, University of Alabama at Birmingham , Birmingham, AL 35233,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4333-5017","authenticated-orcid":false,"given":"F Lennie","family":"Wong","sequence":"additional","affiliation":[{"name":"Population Sciences, City of Hope , Duarte, CA 91919,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8078-8579","authenticated-orcid":false,"given":"Daniel","family":"Weisdorf","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology and Transplantation, University of Minnesota , Minneapolis, MN 55455,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2604-8603","authenticated-orcid":false,"given":"Saro H","family":"Armenian","sequence":"additional","affiliation":[{"name":"Population Sciences, City of Hope , Duarte, CA 91919,","place":["United States"]},{"name":"Pediatric Hematology\/Oncology, City of Hope , Duarte, CA 91919,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7755-5683","authenticated-orcid":false,"given":"Smita","family":"Bhatia","sequence":"additional","affiliation":[{"name":"Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham School of Medicine , Birmingham, AL 35233,","place":["United States"]},{"name":"Division of Pediatric Hematology, Oncology and Bone Marrow Transplantation, University of Alabama at Birmingham , Birmingham, AL 35233,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"key":"2025060819563903500_djaf021-B1","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","article-title":"Current use of and trends in hematopoietic cell transplantation in the United States","volume":"26","author":"D\u2019Souza","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"2025060819563903500_djaf021-B2","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.bbmt.2013.07.020","article-title":"Prevalence of hematopoietic cell transplant survivors in the United States","volume":"19","author":"Majhail","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"2025060819563903500_djaf021-B3","author":"Centers for Disease Control and Prevention","year":"2023"},{"key":"2025060819563903500_djaf021-B4","author":"Surveillance, Epidemiology, and End Results Program","year":"2024"},{"key":"2025060819563903500_djaf021-B5","doi-asserted-by":"crossref","first-page":"djv086","DOI":"10.1093\/jnci\/djv086","article-title":"US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines","volume":"107","author":"Saraiya","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"2025060819563903500_djaf021-B6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1200\/JCO.2001.19.2.464","article-title":"Solid cancers after bone marrow transplantation","volume":"19","author":"Bhatia","year":"2001","journal-title":"J Clin Oncol"},{"key":"2025060819563903500_djaf021-B7","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood-2008-05-158782","article-title":"Solid cancers after allogeneic hematopoietic cell transplantation","volume":"113","author":"Rizzo","year":"2009","journal-title":"Blood"},{"key":"2025060819563903500_djaf021-B8","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1182\/blood-2004-09-3411","article-title":"Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: An international case-control study","volume":"105","author":"Curtis","year":"2005","journal-title":"Blood"},{"key":"2025060819563903500_djaf021-B9","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1200\/JCO.2005.02.7052","article-title":"Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation","volume":"24","author":"Leisenring","year":"2006","journal-title":"J Clin Oncol"},{"key":"2025060819563903500_djaf021-B10","author":"Accurint databases","year":"2023"},{"key":"2025060819563903500_djaf021-B11","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199703273361301","article-title":"Solid cancers after bone marrow transplantation","volume":"336","author":"Curtis","year":"1997","journal-title":"N Engl J Med"},{"key":"2025060819563903500_djaf021-B12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/bmt.2017.210","article-title":"Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: A longitudinal study","volume":"53","author":"Shanis","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"2025060819563903500_djaf021-B13","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.bbmt.2008.07.005","article-title":"Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation\u2014implications for screening and HPV vaccination","volume":"14","author":"Savani","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"2025060819563903500_djaf021-B14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.bmt.1705020","article-title":"Solid tumors after hematopoietic stem cell transplantation in Japan: Incidence, risk factors and prognosis","volume":"36","author":"Shimada","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"2025060819563903500_djaf021-B15","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"2025060819563903500_djaf021-B16","first-page":"1705","article-title":"Recommendations on the use of quadrivalent human papillomavirus vaccine in males\u2014Advisory Committee on Immunization Practices (ACIP), 2011","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025060819563903500_djaf021-B17","doi-asserted-by":"crossref","first-page":"698","DOI":"10.15585\/mmwr.mm6832a3","article-title":"Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices","volume":"68","author":"Meites","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025060819563903500_djaf021-B18","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.15585\/mmwr.mm6549a5","article-title":"Use of a 2-dose schedule for human papillomavirus vaccination\u2014updated recommendations of the Advisory Committee on Immunization Practices","volume":"65","author":"Meites","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025060819563903500_djaf021-B19","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1182\/blood-2015-12-550475","article-title":"How I vaccinate blood and marrow transplant recipients","volume":"127","author":"Carpenter","year":"2016","journal-title":"Blood"},{"key":"2025060819563903500_djaf021-B20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11764-015-0495-2","article-title":"Prevalence and predictors of human papillomavirus (HPV) vaccination among young women surviving childhood cancer","volume":"10","author":"Klosky","year":"2016","journal-title":"J Cancer Surviv"},{"key":"2025060819563903500_djaf021-B21","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1200\/JCO.2017.74.1843","article-title":"Human papillomavirus vaccination rates in young cancer survivors","volume":"35","author":"Klosky","year":"2017","journal-title":"J Clin Oncol"},{"key":"2025060819563903500_djaf021-B22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/LGT.0000000000000468","article-title":"Guidelines for cervical cancer screening in immunosuppressed women without HIV infection","volume":"23","author":"Moscicki","year":"2019","journal-title":"J Low Genit Tract Dis"},{"key":"2025060819563903500_djaf021-B23","author":"U.S. Preventive Services Task Force","year":"2024"},{"key":"2025060819563903500_djaf021-B24","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/sj.bmt.1702419","article-title":"Validation of self-reported complications by bone marrow transplantation survivors","volume":"25","author":"Louie","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"2025060819563903500_djaf021-B25","author":"Children\u2019s Oncology Group","year":"2023"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djaf021\/61706882\/djaf021.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/117\/6\/1166\/61706882\/djaf021.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/117\/6\/1166\/61706882\/djaf021.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T19:56:48Z","timestamp":1749412608000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/117\/6\/1166\/7991297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,1,30]]},"published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djaf021","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,1,30]]}}}